Beschrijving
The protein VSIG3 is a member of the V-set immunoglobulin domain family. It is involved in cell adhesion and has been linked to the regulation of immune responses. VSIG3 expression is detected in a variety of tissues and may have potential therapeutic applications.
Specifications
|
Synonyms |
VSIG3;IgSF11;CXADRL1;Bt-IgSF;CT119 |
|
Uniprot No. |
Q5DX21 |
|
Source |
Recombinant Human VSIG3 Protein is expressed from HEK293 Cells with His tag at the C-terminal. It contains Leu23-Gly241. |
|
Molecular Weight |
The protein has a predicted MW of 24.62 kDa. And it migrates as 30-40 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation. |
|
Purity |
> 95% as determined by SDS-PAGE. |
|
Endotoxin |
<1 EU per 1μg of the protein by the LAL method. |
|
Formulation |
Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). |
|
Reconstitution |
Centrifuge tubes before opening. Dissolve lyophilized protein with sterile PBS to ensure the concentration is greater than 100 ug/mL. |
Storage
The product should be stored at -25~-15℃ for 1 year from the date of receipt.
2-7 days, 2 ~8 °C under sterile conditions after reconstitution.
3 months, -25~-15℃ under sterile conditions after reconstitution.
Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.
Note
1.Please operate with lab coats and disposable gloves,for your safety.
2.This product is for research use only.
Product Data
Betaling en beveiliging
Uw betalingsinformatie wordt veilig verwerkt. We slaan geen creditcardgegevens op en hebben geen toegang tot uw creditcardinformatie.
Navraag
Misschien vind je het ook leuk
FAQ
Het product is alleen bedoeld voor onderzoeksdoeleinden en is niet bedoeld voor therapeutisch of diagnostisch gebruik bij mensen of dieren. Producten en inhoud worden beschermd door patenten, handelsmerken en auteursrechten die eigendom zijn van
Voor bepaalde toepassingen zijn mogelijk aanvullende intellectuele eigendomsrechten van derden vereist.